Ayana Capital

Ayana Capital is a US-based venture capital firm backing pre-seed through Series A companies across North America and Europe, with additional later-stage activity in UK AI-enabled life sciences. It focuses on fintech, healthcare technology, deep tech and AI-enabled life sciences, including biotechnology, medical devices and pharmaceuticals. Typical investments are $1m to $3m in equity or quasi-equity, making it relevant for founders raising venture rounds in these sectors.